The immune system presents significant obstacles to gene therapy, which has limited its use in treating many illnesses. New approaches are needed to overcome these problems and improve the effectiveness of gene therapy. This study explores several techniques to immune regulation within gene therapy, a cutting-edge discipline that aims to optimise results by fine-tuning the immune response. We cover new ways to control the immune system and deliver therapeutic genes just where they are needed, including influencing immunological checkpoints, causing immunotolerance, and making smart use of immunomodulatory drugs. In addition, the study provides insight into new developments in the design of less immunogenic gene delivery vectors, which allow for the extension of transgene expression with minimal adverse immune reactions. In order to maximise the efficacy of gene-based therapies, this review analyses these novel approaches and gives a thorough overview of the present state of the art by addressing obstacles and pointing the way toward future developments in immune regulation. Not only does their integration provide new opportunities for the creation of safer and more effective gene treatments, but it also contains the key to overcome current obstacles.

In cancer diagnostics, deep learning has proven to be astonishingly accurate in evaluating images. Cancer—a complex and multifaceted disease—has thousands of genetic and epigenetic changes. Deep learning is used to detect genetic abnormalities in cancer diagnosis and therapy. The Artificial Intelligence (AI) machine learning acts as a human brain to process data, recognize images, objects and languages, and improve drug development. Artificial neural networks (ANNs) are used to process data for cancer detection. This chapter brings out how AI-based assistance could help oncologists to give an accurate therapy by combining biology and AI. Machine Learning is a subset of AI in which algorithms are built on the basis of neural networks. Deep learning uses an ANN to process data, including medical images, to mimic human neural architecture. In order to decode the molecular start of cancer, clinical oncology research is now more focused on understanding the intricate biological architecture of cancer cell proliferation. Generalize AI, super AI, and tight AI are the three types of AI. With the evolution of AI technology, attempts have been made to construct robots that can perceive biological changes by pulling real-time data and comparing it to data from a population pool for accurate clinical interpretation of cancer test results.